MEK1/2 inhibitors AS703026 and AZD6244 may be potential therapies for KRAS mutated colorectal cancer that is resistant to EGFR monoclonal antibody therapy (Q39625657)
Jump to navigation
Jump to search
scientific article published on 30 November 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MEK1/2 inhibitors AS703026 and AZD6244 may be potential therapies for KRAS mutated colorectal cancer that is resistant to EGFR monoclonal antibody therapy |
scientific article published on 30 November 2010 |
Statements
1 reference
MEK1/2 inhibitors AS703026 and AZD6244 may be potential therapies for KRAS mutated colorectal cancer that is resistant to EGFR monoclonal antibody therapy (English)
1 reference
Kang-Yell Choi
1 reference
Juyong Yoon
1 reference
Kyoung-Hwa Koo
1 reference
30 November 2010
1 reference
1 reference
Identifiers
1 reference